Cell culture fluid holds the world's largest market share; new dry eye drug to enter Phase III clinical trials in Taiwan, the US, and Australia in 2025.

H&Q Asia Pacific Ltd published this content on October 31, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 10, 2026 at 14:22 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]